A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1

Journal of Molecular Biology

Volumn 301, Issue 4, 2000, Pages 817-826

  Trang, Phong ^a   Kilani, Ahmed ^a   Kim, Joseph ^a   Liu, Fenyong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiviral; Gene targeting; Herpes simplex virus; Ribozyme; RNase P

Indexed keywords

RIBONUCLEASE; RIBOZYME; TRANSCRIPTION FACTOR; VIRUS ENZYME;

ARTICLE; ENZYME ANALYSIS; ENZYME SUBUNIT; ESCHERICHIA COLI; GENE TARGETING; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS REPLICATION;

ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1;

EID: 0034714164     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4022     Document Type: Article

References (43)

1. Ribonuclease P
2. Inhibition of human cytomegalovims immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA
3. Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA
4. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region
5. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization
6. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1
7. Antiviral effects of herpes simplex virus specific anti-sense nucleic acids
8. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
9. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
10. Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III
11. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
12. External guide sequences for an RNA enzyme
13. Ribonuclease P: Unity and diversity in a tRNA processing ribozyme
14. Rational design of self-cleaving pre-tRNA-Ribonuclease P RNA conjugates
15. Expression of small, therapeutic RNAs in human cell nuclei
16. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis
17. Inhibition of viral gene expression by human ribonuclease P
18. UV crosslink mapping of the substrate binding site of RNase P ribozyme to a target mRNA sequence
19. The protein cofactor allows the sequence of an RNase P ribozyme to diversify by maintaining the catalytically active structure of the enzyme
20. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors
21. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli
22. Requirements for cleavage by a modified RNase P of a small model substrate
23. The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate
24. Characterization of the protease and other products of amino-terminus-proximal cleavage of the herpes simplex virus 1 UL26 protein
25. Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: Effects on catalytic activity
26. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences
27. Improved retroviral vectors for gene transfer and expression
28. Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)
29. Monitoring retroviral RNA dimerization in vivo via hammerhead ribozyme cleavage
30. Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P
31. Direct measurement of oligonucleotide substrate binding to wild-type and mutant ribozymes from Tetrahymena
32. Herpes simplex viruses and their replication
33. Ribozymes, genomics and therapeutics
34. Ribozymes as potential anti-HIV-1 therapeutic agents
35. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
36. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic subunit of RNase P from Escherichia coli
37. Protein enhancement of hammerhead ribozyme catalysis
38. Herpes simplex viruses
39. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA
40. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1
41. Targeted cleavage of mRNA by human RNase P
42. Analysis of the structure of Tetrahymena nuclear RNAs in vivo: Telomerase RNA, the self-splicing rRNA intron, and U2 snRNA
43. Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus